PMID- 31660883 OWN - NLM STAT- MEDLINE DCOM- 20191230 LR - 20200108 IS - 1471-2334 (Electronic) IS - 1471-2334 (Linking) VI - 19 IP - 1 DP - 2019 Oct 28 TI - Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya. PG - 902 LID - 10.1186/s12879-019-4540-z [doi] LID - 902 AB - BACKGROUND: Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) diseases are globally acknowledged as a public health challenge that exhibits adverse bidirectional relations due to the co-epidemic overlap. To understand the co-infection burden we used the case notification data to generate spatiotemporal maps that described the distribution and exposure hypotheses for further epidemiologic investigations in areas with unusual case notification levels. METHODS: We analyzed the TB and TB-HIV case notification data from the Kenya national TB control program aggregated for forty-seven counties over a seven-year period (2012-2018). Using spatiotemporal poisson regression models within the Integrated Nested Laplace Approach (INLA) paradygm, we modeled the risk of TB-HIV co-infection. Six competing models with varying space-time formulations were compared to determine the best fit model. We then assessed the geographic patterns and temporal trends of coinfection risk by mapping the posterior marginal from the best fit model. RESULTS: Of the total 608,312 TB case notifications, 194,129 were HIV co-infected. The proportion of TB-HIV co-infection was higher in females (39.7%) than in males (27.0%). A significant share of the co-infection was among adults aged 35 to 44 years (46.7%) and 45 to 54 years (42.1%). Based on the Bayesian Defiance Information (DIC) and the effective number of parameters (pD) comparisons, the spatiotemporal model allowing space-time interaction was the best in explaining the geographical variations in TB-HIV coinfection. The model results suggested that the risk of TB-HIV coinfection was influenced by infrastructure index (Relative risk (RR) = 5.75, Credible Interval (Cr.I) = (1.65, 19.89)) and gender ratio (RR = 5.81e(-04), Cr. I = (1.06e(-04), 3.18e(-03)). The lowest and highest temporal relative risks were in the years 2016 at 0.9 and 2012 at 1.07 respectively. The spatial pattern presented an increased co-infection risk in a number of counties. For the spatiotemporal interaction, only a few counties had a relative risk greater than 1 that varied in different years. CONCLUSIONS: We identified elevated risk areas for TB/HIV co-infection and fluctuating temporal trends which could be because of improved TB case detection or surveillance bias caused by spatial heterogeneity in the co-infection dynamics. Focused interventions and continuous TB-HIV surveillance will ensure adequate resource allocation and significant reduction of HIV burden amongst TB patients. FAU - Otiende, Verrah AU - Otiende V AUID- ORCID: 0000-0001-6147-3547 AD - Department of Mathematical Sciences, Pan African University Institute of Basic Sciences Technology and Innovation, Nairobi, Kenya. otiende.verrah@students.jkuat.ac.ke. FAU - Achia, Thomas AU - Achia T AD - School of Mathematics, Statistics & Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa. FAU - Mwambi, Henry AU - Mwambi H AD - School of Mathematics, Statistics & Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa. LA - eng GR - PhD Scholarship/African Union/ PT - Journal Article DEP - 20191028 PL - England TA - BMC Infect Dis JT - BMC infectious diseases JID - 100968551 SB - IM MH - Adolescent MH - Adult MH - Age Factors MH - *Bayes Theorem MH - Coinfection/*epidemiology MH - *Epidemics MH - Female MH - HIV Infections/*epidemiology MH - Humans MH - Kenya/epidemiology MH - Male MH - Middle Aged MH - Poverty MH - Public Health MH - Public Health Surveillance MH - Risk MH - Sex Factors MH - Tuberculosis/*epidemiology MH - Young Adult PMC - PMC6819548 OTO - NOTNLM OT - Bayesian modeling OT - Kenya OT - TB-HIV co-infection OT - co-epidemic burden COIS- The authors declare that they have no competing interests. EDAT- 2019/10/30 06:00 MHDA- 2019/12/31 06:00 PMCR- 2019/10/28 CRDT- 2019/10/30 06:00 PHST- 2019/04/25 00:00 [received] PHST- 2019/10/09 00:00 [accepted] PHST- 2019/10/30 06:00 [entrez] PHST- 2019/10/30 06:00 [pubmed] PHST- 2019/12/31 06:00 [medline] PHST- 2019/10/28 00:00 [pmc-release] AID - 10.1186/s12879-019-4540-z [pii] AID - 4540 [pii] AID - 10.1186/s12879-019-4540-z [doi] PST - epublish SO - BMC Infect Dis. 2019 Oct 28;19(1):902. doi: 10.1186/s12879-019-4540-z.